Pilot & Feasibility Awards 2018

The goal of the Pilot and Feasibility Study Program is to encourage research on diabetes and its complications by two target groups: young researchers in these fields who have not yet received significant NIH or other funding, and seasoned investigators either entering the diabetes field for the first time or exploring a completely new direction.

Two grants to initiate January, 2018 will be awarded to researchers based either at the Joslin Diabetes Center or at neighboring institutions within Harvard Medical School and affiliated hospitals and centers. A second year of funding will be contingent on successful completion of the first year as outlined in a submitted progress report. A special effort is made to foster interactions between Joslin DRC investigators and the external P&F Study Program awardees. This includes facilitating access to Joslin DRC cores, an invitation to give a seminar at the Joslin, and invitations to Joslin retreats and other enrichment activities. Please visit the Enrichment Core portion of the Joslin Research website.

The program has been highly successful since its inception. Projects funded in past years have covered a wide range of topics in the fields of type 1 and type 2 diabetes and their complications, including the control of insulin gene expression, mechanisms of insulin action and resistance, stem cell biology, beta cell apoptosis and potential renewal, mechanisms of leptin action and resistance, and autoantigen therapy of type 1 diabetes. The approaches have also been very diverse, covering wide varieties of biochemical, molecular biologic, genetic, immunological and clinical strategies. This breadth reflects the interests of Joslin’s diabetes research program as a whole; see more about Joslin’s Research Programs.

The application process is a two-step procedure. By midnight of September 15, 2017 the potential candidate should submit an electronic “Letter of Intent.” Received letters will be pre-reviewed for eligibility and priority, and the successful candidates will be asked to electronically submit a five-page proposal following an abbreviated version of a standard NIH application, due by October 13, 2017. These applications will be reviewed and awarded P&Fs will be selected for funding to start on January 1, 2018. The P&F website will open for questions and submissions August 18, 2017.

For further questions about the grant and the application process, email: PandF@Joslin.Harvard.Edu.

Deadline for Letter of Intent:Friday September 15, 2017
Deadline for Full Application (invitation only):Friday October 13, 2017
Decision Announcement:Late December
Funding Cycle: Begins January 1, 2018 and lasts 1 year. A second year of funding is contingent upon positive review of the P&F year 1 progress report.